News

Filter

Current filters:

Restasis

1 to 9 of 134 results

Actavis confirms challenge to Allergan’s Restasis

22-01-2014

Generics drug major Actavis has confirmed that its Watson Laboratories unit has submitted an Abbreviated…

ActavisAllerganGenericsNorth AmericaOphthalmicsPatentsRegulationRestasisUSAWatson Pharmaceuticals

APT Pharma secures $32.3M financing

06-10-2008

APT Pharmaceuticals, a US specialty drug development company focused on inhaled treatments for serious…

3MCyclosporineNeoralRestasisSandimmune

Barr shares fall 15% on disappointing 1st qtr

19-05-2008

Shares in Barr Pharmaceuticals fell 15% in premarket trading on May 8, after the US generics giant reported…

CyclosporineCyclosporine CapsulesGengraf CapsulesNeoralNystatinOralRestasisSandimmune

US fast-track for Lux Biosciences' LX201

04-02-2008

Lux Biosciences, a privately-held US biotechnology company specialized in the field of ophthalmic diseases,…

CyclosporineNeoralRestasisSandimmune

1 to 9 of 134 results

COMPANY SPOTLIGHT

Menarini

Back to top